Specialty and rare disease programs face growing pressure to improve speed to therapy while navigating increasingly complex vendor claims, automation promises and access workflows. This webinar examines how pharmaceutical teams can evaluate the access program process more effectively before committing to a hub vendor transition.
The featured speaker will walk through the questions that should drive every hub vendor evaluation, the performance signals that most brands are not monitoring closely enough and the operational realities of specialty drug access (and where automation can help or hurt).
Drawing on direct experience with hub program transitions and vendor assessments, this webinar will examine what happens when a program is built on incomplete data processed at high speed, what the actual cost of switching vendors looks like when access continuity is at stake and why the metrics that appear in a vendor’s pitch deck are often the least useful indicators of real program performance.
The session will address the specific landscape of specialty and rare disease therapies, where the complexity of prior authorization pathways, payer variability and patient fragility means that execution gaps have consequences that a better dashboard cannot fix.
Attendees will leave with a practical evaluation framework and a clearer understanding of the difference between a vendor that markets access performance and one that can actually deliver it.
Register for this webinar to learn how access program process improvements can help reduce access delays, strengthen vendor evaluation and increase speed to therapy.
Speaker
Paul Battaglia, Chief Operating Officer, Elusa Health
Paul Battaglia has spent his career advising pharmaceutical companies on how to build, evaluate and optimize patient services programs. With direct experience across specialty and rare disease hub programs, Paul has seen firsthand how the gap between vendor marketing and operational execution plays out in patient outcomes and brand performance. Having begun his career as a Program Specialist and holding leadership roles at Theracom, Lash Group and Two Labs, he brings a wealth of knowledge from all levels of the access journey. At Elusa Health, Paul works closely with prospective and current partners to ensure the access program structure aligns with the clinical and commercial complexity of the therapies they support.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Patient Access Directors and Access Program Managers currently evaluating or re-evaluating hub vendor relationships
- Brand Directors and VP of Commercial Operations for specialty and rare disease products
- VP of Patient Services and Hub Operations professionals overseeing program transitions
- Market Access Leads responsible for payer strategy and reimbursement performance
- Managed Markets and Reimbursement teams working on specialty portfolios
- Consultants advising pharmaceutical brands on hub program structure and vendor selection
What You Will Learn
Attendees will gain insight into:
- The specific operational questions to ask any hub vendor before committing to a program transition
- Why speed-focused automation without human verification creates downstream access failures in specialty and rare disease programs
- How to identify whether the current or prospective vendor’s performance metrics reflect real patient outcomes or optimized reporting
- A practical framework for assessing vendor readiness against the actual complexity of the therapy access landscape
Xtalks Partner
Elusa Health
Elusa Health is a patient services platform that partners with pharmaceutical companies to accelerate therapy access through a proprietary CRM, parallel workflows, real-time provider visibility, and dedicated human support. Built on the principle that clarity changes outcomes, Elusa Health combines smart automation with human-verified intelligence to deliver 99% benefit verification accuracy, 4-hour turnaround on benefit verifications, and 90% overturned denial rates on appeals.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account